Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115863862 | 11586386 | 2 | F | 20130618 | 20160630 | 20151001 | 20160817 | PER | US-AEGERION PHARMACEUTICAL INC.-AEGR000565 | AEGERION | 20.42 | YR | F | Y | 49.89000 | KG | 20160817 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115863862 | 11586386 | 1 | PS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 5 MG, QD | 1230 | MG | Y | N | 203858 | 5 | MG | CAPSULE | QD | ||
| 115863862 | 11586386 | 2 | SS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 10 MG, QD | 1230 | MG | Y | N | 203858 | 10 | MG | CAPSULE | QD | ||
| 115863862 | 11586386 | 3 | SS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 20 MG, QD | 1230 | MG | Y | N | 203858 | 20 | MG | CAPSULE | QD | ||
| 115863862 | 11586386 | 4 | SS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 30 MG, QD | 1230 | MG | Y | N | 203858 | 30 | MG | CAPSULE | QD | ||
| 115863862 | 11586386 | 5 | SS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 20 MG, QD | 1230 | MG | Y | N | 203858 | 20 | MG | CAPSULE | QD | ||
| 115863862 | 11586386 | 6 | SS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 30 MG, QD | 1230 | MG | Y | N | 203858 | 30 | MG | CAPSULE | QD | ||
| 115863862 | 11586386 | 7 | SS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 10 MG, QD | 1230 | MG | Y | N | 203858 | 10 | MG | CAPSULE | QD | ||
| 115863862 | 11586386 | 8 | SS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 20 MG, QD | 1230 | MG | Y | N | 203858 | 20 | MG | CAPSULE | QD | ||
| 115863862 | 11586386 | 9 | SS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 30 MG, QD | 1230 | MG | Y | N | 203858 | 30 | MG | CAPSULE | QD | ||
| 115863862 | 11586386 | 10 | SS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 10 MG, QD | 1230 | MG | Y | N | 203858 | 10 | MG | CAPSULE | QD | ||
| 115863862 | 11586386 | 11 | SS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 30 MG, QD | 1230 | MG | Y | N | 203858 | 30 | MG | CAPSULE | QD | ||
| 115863862 | 11586386 | 12 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | 10 MG, QD | Y | U | 0 | 10 | MG | QD | ||||||
| 115863862 | 11586386 | 13 | C | VESTURA | DROSPIRENONEETHINYL ESTRADIOL | 1 | Oral | 3 MG- 20MCG, QD | U | 0 | QD | ||||||||
| 115863862 | 11586386 | 14 | C | EZETIMIBE. | EZETIMIBE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 115863862 | 11586386 | 15 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, QD | U | 0 | 81 | MG | QD | ||||||
| 115863862 | 11586386 | 16 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Oral | 400 IU, QD | U | 0 | 400 | IU | QD | ||||||
| 115863862 | 11586386 | 17 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 115863862 | 11586386 | 18 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 50 MCG, QD | 0 | QD | |||||||||
| 115863862 | 11586386 | 19 | C | LORYNA | DROSPIRENONEETHINYL ESTRADIOL | 1 | Oral | 3 MG - 20 MCG TAB, QD | 0 | QD | |||||||||
| 115863862 | 11586386 | 20 | C | Omega 3 6 9 | FISH OIL | 1 | Oral | 400MG-400MG-400MG, QD | 0 | QD | |||||||||
| 115863862 | 11586386 | 21 | C | ZETIA | EZETIMIBE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115863862 | 11586386 | 1 | Type IIa hyperlipidaemia |
| 115863862 | 11586386 | 12 | Product used for unknown indication |
| 115863862 | 11586386 | 13 | Contraception |
| 115863862 | 11586386 | 14 | Hypercholesterolaemia |
| 115863862 | 11586386 | 15 | Platelet aggregation inhibition |
| 115863862 | 11586386 | 16 | Product used for unknown indication |
| 115863862 | 11586386 | 17 | Hypercholesterolaemia |
| 115863862 | 11586386 | 18 | Product used for unknown indication |
| 115863862 | 11586386 | 19 | Product used for unknown indication |
| 115863862 | 11586386 | 20 | Product used for unknown indication |
| 115863862 | 11586386 | 21 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115863862 | 11586386 | Abdominal distension | |
| 115863862 | 11586386 | Abdominal pain | |
| 115863862 | 11586386 | Diarrhoea | |
| 115863862 | 11586386 | Therapy cessation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115863862 | 11586386 | 1 | 20130315 | 20130413 | 0 | |
| 115863862 | 11586386 | 2 | 20130414 | 20130513 | 0 | |
| 115863862 | 11586386 | 3 | 20130514 | 20130612 | 0 | |
| 115863862 | 11586386 | 4 | 20130613 | 20130628 | 0 | |
| 115863862 | 11586386 | 5 | 20130629 | 20131018 | 0 | |
| 115863862 | 11586386 | 6 | 20131019 | 20131230 | 0 | |
| 115863862 | 11586386 | 7 | 20140124 | 20140222 | 0 | |
| 115863862 | 11586386 | 8 | 20140223 | 20140417 | 0 | |
| 115863862 | 11586386 | 9 | 20140418 | 0 | ||
| 115863862 | 11586386 | 10 | 20150417 | 0 | ||
| 115863862 | 11586386 | 11 | 20150319 | 20160411 | 0 | |
| 115863862 | 11586386 | 12 | 20150410 | 20150415 | 0 | |
| 115863862 | 11586386 | 13 | 20130402 | 0 | ||
| 115863862 | 11586386 | 14 | 200908 | 0 | ||
| 115863862 | 11586386 | 15 | 20121123 | 0 |